Be a part of the WHINN 2018 session on medical cannabis
Denmark has a four-year trial for prescribing medical cannabis. How can we make the best of it?

This year, the WHINN conference hosts the session “DK has a four-year trial for prescribing medical cannabis. How can we make the best of it?”. It will be a great opportunity to broaden your perspective and get new insights on medical cannabis.  
Since 2017, two of the world’s largest players within medical cannabis, Spectrum Cannabis Denmark and Aurora Nordic Cannabis, have opened their facility in Odense. Spectrum Cannabis Denmark is a part of Canopy Growth Corporation, one of the largest producers of medical cannabis in the world with headquarter in Canada. Aurora Nordic Cannabis is a part of the Aurora Cannabis Inc., and was established in Odense primo January 2018 with plans of becoming Europe’s largest producer of medical cannabis.

Furthermore, both OUH Odense University Hospital and University of Southern Denmark are researching the use of medical cannabis. Thus, Odense finds itself in the centre of a rising trend in today’s healthcare.

Four-year trial for prescribing medical cannabis
Medical cannabis is a highly sensitive subject for many. The debate not only affects patients and medical companies, but also relatives, research institutions, gardeners, doctors etc.

In Denmark, three types of cannabis derivates for medical use were approved by the Danish Medicines Agency in 2011, but they require prescription. Cannabis in other forms such as hashish and the raw plant are illegal. However, from 2018, Denmark has a four-year trial for doctors to prescribe medical cannabis to patients. Hence, the question should not be pro or con, but how can we make the best of it?

Looking worldwide, you can find science projects looking at effects and side-effect, and with the trial, we see still more science projects. At the same time, doctors have now been able to prescribe medical cannabis for more than 6 months. What are their experiences? Are there already any learnings? Furthermore, what can we learn from the countries with years of experience in subscribing and using medical cannabis?

How can we make the best of it?
At this track, the leading national and international scientists, doctors and health professionals will share results, knowhow and experiences – among others, Rikke Jakobsen from Cannabis Danmark, an association dedicated on making Denmark a pioneer in the development and use of medical cannabis.

The session is held on Thursday 11th of October in Odense Congress Centre by Invest in Odense. It is a part of the WHINN 2018 conference on health tech and health innovation. You can see the preliminary program for the entire conference here.